Cleveland Medical Devices spin-off company NeuroWave Systems Inc. is poised to introduce its first commercial product — the NeuroSense Monitor — without taking a single investor dollar. NeuroSense is ...

CHICAGO--(BUSINESS WIRE)-- Health care professionals, patients and payors are increasingly seeking safe first-line therapeutic alternatives that provide demonstrated efficacy without drug-related side ...

NeuroWave Systems has received a U.S. Army contract to develop a closed-loop anesthesia system based on a brain-monitoring device the company produces. Cleveland Heights, Ohio-based NeuroWave said its ...

CHICAGO--(BUSINESS WIRE)-- Neurowave Medical Technologies™ (NMT) introduced Nometex™, a new transdermal neuromodulation device to treat patients with chemotherapy-induced nausea and vomiting (CINV), ...

CHICAGO--(BUSINESS WIRE)--Neurowave Medical Technologies™ (NMT) will launch the OTC version of its popular ReliefBand® Voyager, an innovative and highly efficacious Transdermal Neuromodulation Medical ...

NeuroWave Systems Inc. has announced that it's been awarded clearance by the U.S. Food and Drug Administration for its NeuroSENSE® NS-901 Monitor. The Beachwood medical equipment manufacturer ...

Cleveland Medical Devices Inc. has finalized an agreement to license its anesthesia monitoring and seizure detection technologies to NeuroWave Systems Inc., a company that spun off from CleveMed in ...

CHICAGO--(BUSINESS WIRE)--Neurowave Medical Technologies™ today announced the release of an innovative new device for the treatment of post-operative nausea, medically referred to as emesis. Reletex™ ...

Featuring clinically proven, FDA-cleared technology, The Reliefband Neurowave is designed to suit the needs of people whose lives are deeply impacted by nausea. This powerful device allows them to ...